REKHA SEHGAL: Open Payments
NPI 1629019955 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 70 payments from 18 companies in 2025. Trend: 2023 $1,444 · 2024 $1,064 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $185 |
| AstraZeneca Pharmaceuticals LP | 10 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $148 |
| Novo Nordisk Inc | 8 | $141 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Lilly USA, LLC | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Insulet Corporation | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
Products named: Kerendia, AIRSUPRA, REXULTI, LEQVIO, OTEZLA, REPATHA, Ozempic, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
